¿Qué alcance tienen el principio de publicidad de los contratos públicos y la excepción de confidencialidad? A propósito de la sentencia del TJUE de 17 de noviembre de 2022 (Asunto C- 54/21)
CUADERNOS DE DERECHO FARMACÉUTICO Nº 84 JANUARY-MARCH 2023
The purpose of this article is to analyze the ruling of the European Court of Justice of 17 November 2022 (Case C-54/21) and the implications it may have for the debate that exists regarding the confidentiality
of the unitary prices of medicinal product in public tenders versus the principles of publicity and transparency that exist in our legal system, offering an interpretation that makes it possible to combine the conflicting interests and principles from a practical standpoint.